Other languages Jafron Biomedical Co.,Ltd.

Equities

300529

CNE100002995

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 05/05/2024 BST			5-day change	1st Jan Change
29.41 ^CNY	+6.79%		+8.52%	+32.30%

04-26	Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023	CI
04-25	Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023	04-26
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	18/08/23
Jafron Biomedical Co.,Ltd. announces an Equity Buyback for CNY 500 million worth of its shares.	17/07/23
Jafron Biomedical Co.,Ltd. authorizes a Buyback Plan.	16/07/23
Jafron Biomedical Co.,Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 31 May 2023	24/05/23
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
Jafron Biomedical Co.,Ltd. Approves the Cash Dividend for 2022	24/04/23
Jafron Biomedical Co.,Ltd. Approves Director Elections	24/04/23
Jafron Biomedical Co.,Ltd. Announces Profit Distribution Proposal for 2022	31/03/23
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22
Jafron Biomedical Co.,Ltd. Implements Final Cash Dividend (A Shares) for 2021, Payable on 10 June 2022	05/06/22
Jafron Biomedical Co.,Ltd. Approves Profit Distribution	16/05/22
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/04/22
Jafron Biomedical Boosts Final Dividend as 2021 Profit Surges 37%	13/04/22
Jafron Biomedical Co.,Ltd. Announces the Profit Distribution Proposal for 2021	12/04/22
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	11/04/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Jafron Biomedical Co.,Ltd.

Equities

300529

CNE100002995

Other languages

Filters